These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34459114)

  • 1. Review on target domains and natural compound-based inhibitors of fatty acid synthase for anticancer drug discovery.
    Pulla LSS; Begum Ahil S
    Chem Biol Drug Des; 2021 Nov; 98(5):869-884. PubMed ID: 34459114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
    Tan YJ; Ali A; Tee SY; Teo JT; Xi Y; Go ML; Lam Y
    Eur J Med Chem; 2019 Nov; 182():111597. PubMed ID: 31422225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Development of Fatty Acid Synthase Inhibitors as Anticancer Agents.
    Singh S; Karthikeyan C; Moorthy NSHN
    Mini Rev Med Chem; 2020; 20(18):1820-1837. PubMed ID: 32781957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Inhibitor of Fatty Acid Synthase Thioesterase Domain with Improved Cytotoxicity against Breast Cancer Cells and Stability in Plasma.
    Lupien LE; Dunkley EM; Maloy MJ; Lehner IB; Foisey MG; Ouellette ME; Lewis LD; Pooler DB; Kinlaw WB; Baures PW
    J Pharmacol Exp Ther; 2019 Oct; 371(1):171-185. PubMed ID: 31300609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid synthase inhibitors: new directions for oncology.
    Kridel SJ; Lowther WT; Pemble CW
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1817-29. PubMed ID: 17970640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase.
    Fako VE; Wu X; Pflug B; Liu JY; Zhang JT
    J Med Chem; 2015 Jan; 58(2):778-84. PubMed ID: 25513712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?
    Lupu R; Menendez JA
    Curr Pharm Biotechnol; 2006 Dec; 7(6):483-93. PubMed ID: 17168665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridine derivatives as anticancer lead compounds with Fatty Acid Synthase as the target: An in silico-guided in vitro study.
    Amrutha NA; Archana PR; Mohan SG; Anto RJ; Sadasivan C
    J Cell Biochem; 2019 Oct; 120(10):16643-16657. PubMed ID: 31095793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer.
    Crous-Masó J; Palomeras S; Relat J; Camó C; Martínez-Garza Ú; Planas M; Feliu L; Puig T
    Molecules; 2018 May; 23(5):. PubMed ID: 29751678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
    Lee KH; Lee MS; Cha EY; Sul JY; Lee JS; Kim JS; Park JB; Kim JY
    Mol Med Rep; 2017 Apr; 15(4):2163-2173. PubMed ID: 28260110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational screening of fatty acid synthase inhibitors against thioesterase domain.
    Panman W; Nutho B; Chamni S; Dokmaisrijan S; Kungwan N; Rungrotmongkol T
    J Biomol Struct Dyn; 2018 Nov; 36(15):4114-4125. PubMed ID: 29161996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico investigation of lavandulyl flavonoids for the development of potent fatty acid synthase-inhibitory prototypes.
    Oh J; Liu H; Park HB; Ferreira D; Jeong GS; Hamann MT; Doerksen RJ; Na M
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3180-3188. PubMed ID: 27531709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.
    Puig T; Aguilar H; Cufí S; Oliveras G; Turrado C; Ortega-Gutiérrez S; Benhamú B; López-Rodríguez ML; Urruticoechea A; Colomer R
    Breast Cancer Res; 2011; 13(6):R131. PubMed ID: 22177475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and anticancer activity of some novel 1H-benzo[d]imidazole-5-carboxamide derivatives as fatty acid synthase inhibitors.
    Singh S; Paul S; Brás NF; Kundu CN; Karthikeyan C; Moorthy NSHN
    Bioorg Chem; 2023 Sep; 138():106658. PubMed ID: 37331170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the development of fatty acid synthase inhibitors as anticancer targets.
    Mullen GE; Yet L
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4363-9. PubMed ID: 26364942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fatty acid synthase: a new anti-tumor target].
    Puig T; Porta R; Colomer R
    Med Clin (Barc); 2009 Mar; 132(9):359-63. PubMed ID: 19268984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic MALDI-TOF Cell-Based Assay for the Discovery of Potent and Specific Fatty Acid Synthase Inhibitors.
    Weigt D; Parrish CA; Krueger JA; Oleykowski CA; Rendina AR; Hopf C
    Cell Chem Biol; 2019 Sep; 26(9):1322-1331.e4. PubMed ID: 31279605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitors.
    Angeles TS; Hudkins RL
    Expert Opin Drug Discov; 2016 Dec; 11(12):1187-1199. PubMed ID: 27701891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?
    Lupu R; Menendez JA
    Endocrinology; 2006 Sep; 147(9):4056-66. PubMed ID: 16809439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).
    Martin MW; Lancia DR; Li H; Schiller SER; Toms AV; Wang Z; Bair KW; Castro J; Fessler S; Gotur D; Hubbs SE; Kauffman GS; Kershaw M; Luke GP; McKinnon C; Yao L; Lu W; Millan DS
    Bioorg Med Chem Lett; 2019 Apr; 29(8):1001-1006. PubMed ID: 30803804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.